PL362705A1 - Szczepionka - Google Patents

Szczepionka

Info

Publication number: PL362705A1
Authority: PL; Poland
Prior art keywords: enveloped virus; intranasal delivery; virus preparation; split enveloped; split
Prior art date: 2000-10-02

Application number

PL01362705A

Other languages

English (en)

Inventor

Brigitte Desiree Alberte Colau

Marguerite Deschamps

Original Assignee

Glaxosmithkline Biologicals S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-02

Filing date

2001-10-01

Publication date

2004-11-02

2001-10-01 Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.

2004-11-02 Publication of PL362705A1 publication Critical patent/PL362705A1/pl

Links

241000700605 Viruses Species 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PL01362705A 2000-10-02 2001-10-01 Szczepionka PL362705A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0024089.5A GB0024089D0 (en)	2000-10-02	2000-10-02	Novel compounds
PCT/EP2001/011326 WO2002028422A2 (en)	2000-10-02	2001-10-01	Split enveloped virus preparation for intranasal delivery

Publications (1)

Publication Number	Publication Date
PL362705A1 true PL362705A1 (pl)	2004-11-02

Family

ID=9900509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01362705A PL362705A1 (pl)	2000-10-02	2001-10-01	Szczepionka

Country Status (16)

Country	Link
US (1)	US20040022808A1 (pl)
EP (1)	EP1324769A2 (pl)
JP (1)	JP2004510744A (pl)
KR (1)	KR20030031200A (pl)
CN (1)	CN1477971A (pl)
AU (1)	AU2002213984A1 (pl)
BR (1)	BR0114393A (pl)
CA (1)	CA2427842A1 (pl)
CZ (1)	CZ2003931A3 (pl)
GB (1)	GB0024089D0 (pl)
HU (1)	HUP0302643A2 (pl)
IL (1)	IL155072A0 (pl)
NO (1)	NO20031483L (pl)
PL (1)	PL362705A1 (pl)
WO (1)	WO2002028422A2 (pl)
ZA (1)	ZA200302522B (pl)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2503774C (en)	2003-06-20	2007-09-25	Microbix Biosystems Inc.	Improvements in virus production
EP1701738B1 (en)	2003-12-17	2015-03-11	Wyeth LLC	Method for producing storage stable RSV compositions
CN1305526C (zh) *	2003-12-29	2007-03-21	薛平	乙型脑炎病毒裂解疫苗及其制备方法
JP5600375B2 (ja)	2004-03-09	2014-10-01	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	インフルエンザウイルスワクチン
ES2525518T3 (es)	2005-11-01	2014-12-26	Novartis Vaccines And Diagnostics Gmbh	Vacunas virales derivadas de células con niveles reducidos de ADN celular residual
NZ594482A (en)	2005-11-04	2012-11-30	Novartis Vaccines & Diagnostic	Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant
CA2628152C (en)	2005-11-04	2016-02-02	Novartis Vaccines And Diagnostics S.R.L.	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
JP2009514844A (ja)	2005-11-04	2009-04-09	ノバルティスヴァクシンズアンドダイアグノスティクスエスアールエル	スプリットインフルエンザワクチン用のアジュバントとしての遊離水相界面活性剤を含むエマルション
NZ568211A (en)	2005-11-04	2011-11-25	Novartis Vaccines & Diagnostic	Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
CN102755645A (zh)	2005-11-04	2012-10-31	诺华疫苗和诊断有限公司	佐剂配制的包含细胞因子诱导剂的流感疫苗
PL2478916T3 (pl)	2006-01-27	2020-11-16	Seqirus UK Limited	Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
CN101448523A (zh)	2006-03-24	2009-06-03	诺华疫苗和诊断有限两合公司	无需冷藏储存流感疫苗
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
EP4585610A3 (en)	2006-09-11	2025-09-24	Seqirus UK Limited	Making influenza virus vaccines without using eggs
US20110053248A1 (en) *	2006-10-23	2011-03-03	Medimmune, Llc	Serum-Free Virus Propagation Platform For A Virus Vaccine Candidate
PT2121011E (pt)	2006-12-06	2014-07-31	Novartis Ag	Vacinas compreendendo um antigénio a partir de quatro estirpes do vírus da gripe
KR20100045437A (ko)	2007-06-27	2010-05-03	노파르티스 아게	첨가물이 적은 인플루엔자 백신
EP2192917B1 (en) *	2007-08-28	2014-01-29	Baxter International Inc.	Method for producing viral vaccines
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
AU2008339631B2 (en)	2007-12-24	2014-07-24	Novartis Ag	Assays for adsorbed influenza vaccines
JP5518041B2 (ja)	2008-03-18	2014-06-11	ノバルティスアーゲー	インフルエンザウイルスワクチン抗原の調製における改良
CA2741961A1 (en)	2008-11-05	2010-05-14	Glaxosmithkline Biologicals S.A.	Novel method
WO2010079081A1 (en)	2009-01-07	2010-07-15	Glaxosmithkline Biologicals S.A.	Methods for recovering a virus or a viral antigen produced by cell culture
US20110293660A1 (en)	2009-02-06	2011-12-01	Bruno Rene Andre	Novel method
EP3173097A3 (en)	2009-02-10	2017-07-12	Seqirus UK Limited	Influenza vaccines with reduced amounts of squalene
EA201171032A1 (ru)	2009-02-10	2012-02-28	Новартис Аг	Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами
CA2752041A1 (en)	2009-02-10	2010-08-19	Novartis Ag	Influenza vaccines with increased amounts of h3 antigen
USH2283H1 (en)	2009-04-27	2013-09-03	Novartis Ag	Vaccines for protecting against influenza
EA021009B1 (ru)	2009-05-21	2015-03-31	Новартис Аг	ОБРАТНАЯ ГЕНЕТИКА С ИСПОЛЬЗОВАНИЕМ НЕЭНДОГЕННЫХ ПРОМОТОРОВ pol I
JP5716297B2 (ja)	2009-06-25	2015-05-13	Jnc株式会社	クロマトグラフィー用充填剤、その製造方法、およびそれを用いたウイルス用ワクチンの製造方法
CN104862335A (zh)	2009-07-31	2015-08-26	诺华股份有限公司	反向遗传系统
US20120237536A1 (en)	2009-09-10	2012-09-20	Novartis	Combination vaccines against respiratory tract diseases
JP5774010B2 (ja)	2009-09-25	2015-09-02	グラクソスミスクラインバイオロジカルズソシエテアノニム	インフルエンザウイルスのための免疫拡散アッセイ
CA2778332A1 (en)	2009-10-20	2011-04-28	Novartis Ag	Improved reverse genetics methods for virus rescue
CA2797059A1 (en)	2010-05-03	2011-11-10	Glaxosmithkline Biologicals S.A.	Novel method
US9426989B2 (en)	2010-05-06	2016-08-30	Novartis Ag	Organic peroxide compounds for microorganism inactivation
CN103025350A (zh)	2010-05-21	2013-04-03	诺华有限公司	流感病毒的重配方法
CA2801151A1 (en)	2010-06-01	2011-12-08	Novartis Ag	Concentration of vaccine antigens with lyophilization
WO2011151723A2 (en)	2010-06-01	2011-12-08	Novartis Ag	Concentration of vaccine antigens without lyophilization
WO2011154976A2 (en)	2010-06-08	2011-12-15	Panacea Biotec Limited	Improved influenza vaccine
WO2012023044A1 (en)	2010-08-20	2012-02-23	Novartis Ag	Soluble needle arrays for delivery of influenza vaccines
GB201216121D0 (en)	2012-09-10	2012-10-24	Novartis Ag	Sample quantification by disc centrifugation
EP2768528A1 (en)	2011-10-20	2014-08-27	Novartis AG	Adjuvanted influenza b virus vaccines for pediatric priming
CN103608453B (zh)	2012-03-02	2018-07-24	思齐乐	流感病毒重配
EP2822585B1 (en)	2012-03-06	2017-05-17	Janssen Vaccines & Prevention B.V.	Improved vaccination against influenza
EP2855701A1 (en)	2012-06-04	2015-04-08	Novartis AG	Improved safety testing
KR102435054B1 (ko)	2012-08-01	2022-08-22	버베리안 노딕 에이/에스	재조합 변형된 백시니아 바이러스 앙카라(ankara) (mva) 호흡기 신시티알 바이러스(rsv) 백신
GB201218195D0 (en)	2012-10-10	2012-11-21	Istituto Zooprofilattico Sperimentale Delle Venezie	Composition
KR20150110494A (ko)	2012-12-03	2015-10-02	노파르티스 아게	재배열 인플루엔자 a 바이러스
CN109045294A (zh)	2013-01-10	2018-12-21	思齐乐	流感病毒免疫原性组合物及其应用
SG11201507454XA (en)	2013-03-13	2015-10-29	Novartis Ag	Influenza b virus reassortment
SG11201509265SA (en)	2013-05-10	2015-12-30	Novartis Ag	Avoiding narcolepsy risk in influenza vaccines
DE202013005130U1 (de)	2013-06-05	2013-09-10	Novartis Ag	Influenza Virus Reassortierung
DE202013005100U1 (de)	2013-06-05	2013-08-26	Novartis Ag	Influenza Virus Reassortierung
CN105722976A (zh)	2013-06-06	2016-06-29	诺华股份有限公司	流感病毒重配
JP6851827B2 (ja) *	2013-08-30	2021-03-31	グラクソスミスクラインバイオロジカルズソシエテアノニム	細胞培養中でのウイルスの大規模製造
JP6373376B2 (ja)	2013-11-15	2018-08-15	ノバルティスアーゲー	残留細胞培養不純物の除去
CN105250280B (zh)	2014-07-14	2020-03-10	诺维科国际控股股份有限公司	包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
FR3025107B1 (fr)	2014-08-29	2018-10-05	Calixar	Procede de preparation d'un antigene vaccinal, antigene vaccinal obtenu et utilisations
BE1023903B1 (fr)	2014-12-16	2017-09-08	Glaxosmithkline Biologicals Sa	Nouveau procédé
US11013795B2 (en)	2015-06-26	2021-05-25	Seqirus UK Limited	Antigenically matched influenza vaccines
KR102790570B1 (ko)	2015-07-07	2025-04-04	세퀴러스 유케이 리미티드	인플루엔자 효능 검정
CN107085095A (zh) *	2017-03-02	2017-08-22	江苏华冠生物技术股份有限公司	用作酶联试剂盒包被抗原的麻疹病毒裂解液的制备方法
AU2020228151A1 (en)	2019-02-25	2021-10-21	Seqirus UK Limited	Adjuvanted multivalent influenza vaccines
SG11202109801YA (en)	2019-03-19	2021-10-28	Amgen Inc	Alternate detergents for viral inactivation
KR20220098370A (ko)	2019-11-07	2022-07-12	세퀴러스 유케이 리미티드	감소된 입자 크기를 가지는 바이러스 백신을 제조하기 위한 조성물 및 방법
EP4061930A1 (en)	2019-11-18	2022-09-28	Seqirus Pty Ltd	Method for producing reassortant influenza viruses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4005528C2 (de) *	1990-02-22	1998-01-15	Pfeiffer Erich Gmbh & Co Kg	Austragvorrichtung für Medien
PL355287A1 (pl) *	1999-09-24	2004-04-05	Smithkline Beecham Biologicals S.A.	Donosowa szczepionka przeciw wirusowi grypy

2000
- 2000-10-02 GB GBGB0024089.5A patent/GB0024089D0/en not_active Ceased
2001
- 2001-10-01 CN CNA018198074A patent/CN1477971A/zh active Pending
- 2001-10-01 HU HU0302643A patent/HUP0302643A2/hu unknown
- 2001-10-01 IL IL15507201A patent/IL155072A0/xx unknown
- 2001-10-01 BR BR0114393-0A patent/BR0114393A/pt not_active Application Discontinuation
- 2001-10-01 CZ CZ2003931A patent/CZ2003931A3/cs unknown
- 2001-10-01 KR KR10-2003-7004719A patent/KR20030031200A/ko not_active Withdrawn
- 2001-10-01 US US10/381,354 patent/US20040022808A1/en not_active Abandoned
- 2001-10-01 CA CA002427842A patent/CA2427842A1/en not_active Abandoned
- 2001-10-01 EP EP01982385A patent/EP1324769A2/en not_active Withdrawn
- 2001-10-01 AU AU2002213984A patent/AU2002213984A1/en not_active Abandoned
- 2001-10-01 WO PCT/EP2001/011326 patent/WO2002028422A2/en not_active Ceased
- 2001-10-01 PL PL01362705A patent/PL362705A1/pl unknown
- 2001-10-01 JP JP2002532246A patent/JP2004510744A/ja active Pending
2003
- 2003-03-31 ZA ZA200302522A patent/ZA200302522B/en unknown
- 2003-04-01 NO NO20031483A patent/NO20031483L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL155072A0 (en)	2003-10-31
CN1477971A (zh)	2004-02-25
EP1324769A2 (en)	2003-07-09
CZ2003931A3 (cs)	2003-10-15
BR0114393A (pt)	2003-08-26
US20040022808A1 (en)	2004-02-05
HUP0302643A2 (hu)	2003-11-28
KR20030031200A (ko)	2003-04-18
NO20031483L (no)	2003-05-28
CA2427842A1 (en)	2002-04-11
ZA200302522B (en)	2004-06-30
JP2004510744A (ja)	2004-04-08
WO2002028422A2 (en)	2002-04-11
NO20031483D0 (no)	2003-04-01
AU2002213984A1 (en)	2002-04-15
GB0024089D0 (en)	2000-11-15
WO2002028422A3 (en)	2002-08-29

Legal Events

Date	Code	Title	Description
2011-02-28	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
PL362705A1 (pl)	2004-11-02	Szczepionka
HUP0302636A3 (en)	2008-03-28	Split enveloped virus preparation
GB0020953D0 (en)	2000-10-11	Vaccine
HUP0301043A3 (en)	2011-03-28	Vaccine
AU4433702A (en)	2002-04-29	Vaccines
AU8189501A (en)	2002-01-08	Vaccine composition
AU7087901A (en)	2002-02-05	Modified virus
GB0014288D0 (en)	2000-08-02	Vaccine
GB0026334D0 (en)	2000-12-13	Vaccine
GB0014845D0 (en)	2000-08-09	Vaccine
HK1057703A (en)	2004-04-16	Split enveloped virus preparation for intranasal delivery
GB0025694D0 (en)	2000-12-06	Vaccine
GB9925432D0 (en)	1999-12-29	Virus preparation
GB0003082D0 (en)	2000-03-29	Vaccine
GB0006693D0 (en)	2000-05-10	Vaccine
GB0015722D0 (en)	2000-08-16	Vaccine
GB0004533D0 (en)	2000-04-19	Vaccines
GB0015935D0 (en)	2000-08-23	Vaccine
GB0006770D0 (en)	2000-05-10	Vaccine composition
WO2002008390A3 (en)	2002-04-25	Bovine wasting syndrome vaccine
GB9925434D0 (en)	1999-12-29	Virus Preparation
GB0005240D0 (en)	2000-04-26	Vaccine
GB0025575D0 (en)	2000-12-06	Vaccine
GB0025573D0 (en)	2000-12-06	Vaccine
GB0025574D0 (en)	2000-12-06	Vaccine